Pfizer's Prevnar 20 Edges Closer To Infant Market, But Phase III Raises Some Questions

 
• By Jessica Merrill
  
babies
Pfizer hopes to get Prevnar 20 approved for infants • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D